Experimental procedures
Radiochemical stability of the 111 In-labeled particles. The stability of the [ 111 In]In-DPEG-TOPSi particles, prepared by both approaches, were investigated in vitro in 1 x PBS (pH = 7.4) and human plasma 10%. For the stability tests freshly prepared [ 111 In]In-DPEG-TOPSi particles (0.5 mg) were added to 1 ml of PBS or plasma solution in LowBind Eppendorf tubes and incubated at 37°C under constant shaking. At predetermined time points (1 h, 2 h and 5 h) samples were centrifuged and the radioactivity of pellet and supernatant were measured by dose calibrator (VDC-405, Veenstra Instruments). All assays were carried out in triplicate. Figure S1 . In vitro stability of [ 111 In]In-DPEG-TOPSi particles in 10% human plasma and 1 x PBS (n = 3). The particles were radiolabeled either by using the one step Approach A or the two-step Approach B, in which the particles were radiolabeled by using a presynthesized [ 111 In]In-DOTA-PEG4-Tz ([ 111 In]1). Figure S4 . 1 H-NMR spectra from DOTA-PEG4-Tz (1).
Figure S5
. Autoradiography image from 4T1 tumor slices collected at 1h and 24h after [ 111 In]In-DPEG-TOPSi administration.
